欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SI/H/0307/002
药品名称Bortezomib Viatris 3.5 mg powder for solution for injection
活性成分
    • Bortezomib 3.5 mg
剂型Powder for solution for injection
上市许可持有人Viatris Limited Damastown Industrial Park, Mulhuddart Dublin 15, Dublin Ireland
参考成员国 - 产品名称Slovenia (SI)
互认成员国 - 产品名称
    • France (FR)
    • Portugal (PT)
    • Germany (DE)
      Bortezomib Mylan 3,5 mg Pulver zur Herstellung einer Injektionslösung
    • Finland (FI)
    • Denmark (DK)
    • Ireland (IE)
    • Greece (GR)
    • Austria (AT)
    • Italy (IT)
    • Spain (ES)
    • United Kingdom (Northern Ireland) (XI)
    • Norway (NO)
许可日期2018/03/13
最近更新日期2025/01/17
药物ATC编码
    • L01XX32 bortezomib
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase